APA (7th ed.) Citation

Bramlage, P., Schmieder, R. E., Gitt, A. K., Baumgart, P., Mahfoud, F., Buhck, H., . . . Potthoff, S. A. (2015). The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: Insights from the prospective EARLY registry. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

Chicago Style (17th ed.) Citation

Bramlage, Peter, Roland E. Schmieder, Anselm K. Gitt, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, and Sebastian A. Potthoff. The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared with the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights from the Prospective EARLY Registry. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.

MLA (9th ed.) Citation

Bramlage, Peter, et al. The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared with the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights from the Prospective EARLY Registry. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.